Squarepoint Ops LLC Viking Therapeutics, Inc. Put Options Transaction History

Squarepoint Ops LLC

  • $93.7 Billion
  • Q2 2025

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$19.98 - $29.49 $1.4 Million - $2.06 Million
-69,900 Reduced 56.33%
54,200 $1.44 Million
Q1 2025

May 15, 2025
BUY
$24.15 - $42.89 $2.31 Million - $4.1 Million
95,700 Added 336.97%
124,100 $3 Million
Q4 2024

Feb 14, 2025
BUY
$38.28 - $78.03 $279,444 - $569,619
7,300 Added 34.6%
28,400 $1.14 Million
Q3 2024

Nov 14, 2024
BUY
$49.84 - $70.47 $1.05 Million - $1.49 Million
21,100 New
21,100 $1.34 Million

Others Institutions Holding VKTX

# of Institutions
448
Shares Held
66.9M
Call Options Held
7.9M
Put Options Held
3.39M
View Full List

About Viking Therapeutics, Inc.

VKTX Quotes by TradingView
  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $3.06B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email